Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Biliary Tract Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    April 2017
  1. HUO X, Zhang X, Yu C, Cheng E, et al
    Aspirin prevents NF-kappaB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
    Gut. 2017 Apr 25. pii: gutjnl-2016-313584. doi: 10.1136/gutjnl-2016-313584.
    PubMed     Text format     Abstract available


  2. TRIVEDI PJ, Tickle J, Vesterhus MN, Eddowes PJ, et al
    Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.
    Gut. 2017 Apr 20. pii: gutjnl-2016-312354. doi: 10.1136/gutjnl-2016-312354.
    PubMed     Text format     Abstract available


    March 2017
  3. HANN A, Zizer E, Egger K, Allescher HD, et al
    Fatal outcome due to CO2 emboli during direct cholangioscopy.
    Gut. 2017 Mar 30. pii: gutjnl-2017-313988. doi: 10.1136/gutjnl-2017-313988.
    PubMed     Text format    


    February 2017
  4. TANG R, Wei Y, Li Y, Chen W, et al
    Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
    Gut. 2017 Feb 17. pii: gutjnl-2016-313332. doi: 10.1136/gutjnl-2016-313332.
    PubMed     Text format     Abstract available


    January 2017
  5. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Text format     Abstract available


    December 2016
  6. FERNANDEZ-BARRENA MG, Perugorria MJ, Banales JM
    Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis.
    Gut. 2016 Dec 16. pii: gutjnl-2016-312899. doi: 10.1136/gutjnl-2016-312899.
    PubMed     Text format    


    September 2016
  7. SINGH A, Smith PJ, Cropley IM, Planche KL, et al
    Gallstone mimicry: a rare cause of abdominal pain.
    Gut. 2016 Sep 29. pii: gutjnl-2016-312706. doi: 10.1136/gutjnl-2016-312706.
    PubMed     Text format    


  8. IWASAWA K, Suda W, Tsunoda T, Oikawa-Kawamoto M, et al
    Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312533. doi: 10.1136/gutjnl-2016-312533.
    PubMed     Text format    


  9. CAROTENUTO P, Fassan M, Pandolfo R, Lampis A, et al
    Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2016 Sep 12. pii: gutjnl-2016-312278. doi: 10.1136/gutjnl-2016-312278.
    PubMed     Text format     Abstract available



  10. Erratum: Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.
    Gut. 2016;65:1571.
    PubMed     Text format    


  11. RIZVI S, Yang JD, Gores GJ
    Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?
    Gut. 2016 Sep 1. pii: gutjnl-2016-312492. doi: 10.1136/gutjnl-2016-312492.
    PubMed     Text format    


    July 2016
  12. JENDREK ST, Gotthardt D, Nitzsche T, Widmann L, et al
    Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
    Gut. 2016 Jul 12. pii: gutjnl-2016-311739. doi: 10.1136/gutjnl-2016-311739.
    PubMed     Text format     Abstract available


  13. KARLSEN TH
    Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love?
    Gut. 2016 Jul 11. pii: gutjnl-2016-312137. doi: 10.1136/gutjnl-2016-312137.
    PubMed     Text format    


    June 2016
  14. KUMMEN M, Hov JR
    Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Ruhlemann et al.
    Gut. 2016 Jun 23. pii: gutjnl-2016-312347. doi: 10.1136/gutjnl-2016-312347.
    PubMed     Text format    


    May 2016
  15. RUHLEMANN MC, Heinsen FA, Zenouzi R, Lieb W, et al
    Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.
    Gut. 2016 May 23. pii: gutjnl-2016-312180. doi: 10.1136/gutjnl-2016-312180.
    PubMed     Text format    


  16. SABINO J, Vieira-Silva S, Machiels K, Joossens M, et al
    Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Gut. 2016 May 20. pii: gutjnl-2015-311004. doi: 10.1136/gutjnl-2015-311004.
    PubMed     Text format     Abstract available


  17. DUPARC T, Plovier H, Marrachelli VG, Van Hul M, et al
    Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Gut. 2016 May 5. pii: gutjnl-2015-310904. doi: 10.1136/gutjnl-2015-310904.
    PubMed     Text format     Abstract available


    February 2016
  18. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis.
    Gut. 2016 Feb 26. pii: gutjnl-2016-311452. doi: 10.1136/gutjnl-2016-311452.
    PubMed     Text format    


  19. KUMMEN M, Holm K, Anmarkrud JA, Nygard S, et al
    The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Gut. 2016 Feb 17. pii: gutjnl-2015-310500. doi: 10.1136/gutjnl-2015-310500.
    PubMed     Text format     Abstract available


    January 2016
  20. WALTER D, Teoh AY, Itoi T, Perez-Miranda M, et al
    EUS-guided gall bladder drainage with a lumen-apposing metal stent: a prospective long-term evaluation.
    Gut. 2016;65:6-8.
    PubMed     Text format    


    October 2015
  21. RODRIGUES CM, Moshage H
    Targeting TGR5 in cholangiocyte proliferation: default topic.
    Gut. 2015 Oct 28. pii: gutjnl-2015-310812. doi: 10.1136/gutjnl-2015-310812.
    PubMed     Text format    


    September 2015
  22. REICH M, Deutschmann K, Sommerfeld A, Klindt C, et al
    TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro.
    Gut. 2015 Sep 29. pii: gutjnl-2015-309458. doi: 10.1136/gutjnl-2015-309458.
    PubMed     Text format     Abstract available


  23. BARON TH, Grimm IS
    Relief of obstructive jaundice from pancreatic cancer: the end of the plastic stent era?
    Gut. 2015 Sep 29. pii: gutjnl-2015-310519. doi: 10.1136/gutjnl-2015-310519.
    PubMed     Text format    


  24. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    


  25. VALENTIN N, Camilleri M, Altayar O, Vijayvargiya P, et al
    Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis.
    Gut. 2015 Sep 7. pii: gutjnl-2015-309889. doi: 10.1136/gutjnl-2015-309889.
    PubMed     Text format     Abstract available


    August 2015
  26. TOL JA, van Hooft JE, Timmer R, Kubben FJ, et al
    Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer.
    Gut. 2015 Aug 25. pii: gutjnl-2014-308762. doi: 10.1136/gutjnl-2014-308762.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: